LICOPID (Glucosaminyl muramyl dipeptide) is a high-tech drug with a wide spectrum of action. The development of the drug and the study of its properties have been going on for over 20 years. Joint efforts of leading experts from Russia, Great Britain, Australia, Latvia have been invested in the development of the drug. The work on the creation of Licopid was assessed as a serious achievement of domestic science in the treatment of many immune-dependent disorders. The topic "Development and creation of biotechnological production of Licopid - a new immunocorrective drug" was in 1996 awarded the Russian Federation Government Prize in the field of science and technology. Recent discoveries in the field of immunology, for which the Nobel Prize in Medicine was awarded, have helped to understand the mechanism of action of immunomodulators of microbial origin through innate immunity receptors.
- Prevention and reduction of seasonal incidence of acute respiratory infections and reduction of the number of exacerbations and relapses.
- Acute and chronic purulent-inflammatory disorders of the skin and soft tissues (pyoderma, furunculosis and others).
- Respiratory tract diseases: rhinitis, laryngitis, tonsillitis, bronchitis, sinusitis, pharyngitis and others.
- Herpes infection (including ophthalmic herpes).
- Sexually transmitted infections (human papillomavirus infection, chronic trichomoniasis).
- Psoriasis (including psoriatic arthritis).
GUARANTEE & EXPIRY DAY
100% original from the Russian Skopinskyi Pharmacaeutical Company. Expiry date up to 02.2025.
Licopid is a representative of the latest generation of bacterial immunomodulators, containing minimal biologically active fragments (MBAF). MBAF, being the smallest fragment of the bacterial wall, is a part of beneficial bacteria. Licopid is effective in the treatment of bacterial, fungal, viral diseases with frequent recurrences throughout the year. Licopid stimulates all parts of the immune system. The action of Licopid is most closely related to the process of natural immunoregulation. Licopid is free of bacterial contaminants that could cause side effects. The mechanism of action has been studied at the molecular level.
PACKAGE & DOSAGE
The medication is taken orally on an empty stomach, 30 minutes before meals.
Active ingredient: Glucosaminyl muramyl dipeptide - 1 or 10 per tablet.
Excipients: core: lactose monohydrate - 184.7 mg, sucrose (sugar) - 12.5 mg, potato starch - 40 mg, methylcellulose - 0.3 mg, calcium stearate - 2.5 mg.
Purulent-inflammatory diseases of the skin and soft tissues, acute and chronic, severe, including purulent-septic postoperative complications: 10 mg once a day for 10 days.
Herpetic infection (recurrent course, severe forms): 10 mg once aday for 6 days.
Ophthalmic herpes: 10 mg twicw a day for 3 days. After a break of 3 days, the course of treatment is repeated.
Sexually transmitted infections (human papillomavirus infection, chronic trichomoniasis): with human papillomavirus infection: 10 mg once a day for 10 days, in chronic trichomoniasis: 10 mg once a day for 10 days.
Psoriasis: 10-20 mg once a day for 10 days and then five doses every other day, 10-20 mg once a day.
In severe psoriasis and extensive lesions (including psoriatic arthritis): 10 mg 2 times a day for 20 days.
Pulmonary tuberculosis: 10 mg once a day for 10 days.
It is recommended to store the medicine in a dark place at a temperature not exceeding 25°C.
Ask us any questions about Licopid.